Hi everyone,

I am a biotech CDMO representative and my goal for this year is to build & expand a portfolio of analytical methods and manufacturing practices to prepare business proposals accordingly. I have been reading a lot of industry press, but nowhere can I find a numerical or percentage breakdown of the demand for such services (CDMO) in the biotechnology industry. Can you list what processes are causing you problems and which ones you would like to outsource?

Please assume no concerns about the quality of execution of the methods or processes in question and omit the issues of technology transfer and contractor equipment from your assessment. Please assume an optimistic scenario of cooperation.

I would greatly appreciate you pointing to sources if you have access to them.

I open the discussion and wish you the best day

More Jakub Knurek's questions See All
Similar questions and discussions